Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis

Alterations in renal elimination processes of glomerular filtration and active tubular secretion by renal transporters can result in adverse drug reactions. Nonalcoholic steatohepatitis (NASH) alters hepatic transporter expression and xenobiotic elimination, but until recently, renal transporter alt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug metabolism and disposition 2023-08, Vol.51 (8), p.970-981
Hauptverfasser: Frost, Kayla L, Jilek, Joseph L, Toth, Erica L, Goedken, Michael J, Wright, Stephen H, Cherrington, Nathan J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 981
container_issue 8
container_start_page 970
container_title Drug metabolism and disposition
container_volume 51
creator Frost, Kayla L
Jilek, Joseph L
Toth, Erica L
Goedken, Michael J
Wright, Stephen H
Cherrington, Nathan J
description Alterations in renal elimination processes of glomerular filtration and active tubular secretion by renal transporters can result in adverse drug reactions. Nonalcoholic steatohepatitis (NASH) alters hepatic transporter expression and xenobiotic elimination, but until recently, renal transporter alterations in NASH were unknown. This study investigates renal transporter changes in rodent models of NASH to identify a model that recapitulates human alterations. Quantitative protein expression by surrogate peptide liquid chromatography-coupled mass spectrometry (LC-MS/MS) on renal biopsies from NASH patients was used for concordance analysis with rodent models, including methionine/choline deficient (MCD), atherogenic (Athero), or control rats and MCD ( ), C57BL/6J fast-food thioacetamide (FFDTH), American lifestyle-induced obesity syndrome (ALIOS), or control mice. Demonstrating clinical similarity to NASH patients, FFDTH, and ALIOS showed decreases in glomerular filtration rate (GFR) by 76%, 28%, and 24%. Organic anion transporter 3 (OAT3) showed an upward trend in all models except the FFDTH (from 3.20 to 2.39 pmol/mg protein), making the latter the only model to represent human OAT3 changes. OAT5, a functional ortholog of human OAT4, significantly decreased in FFDTH, and ALIOS (from 4.59 to 0.45, 1.59, and 2.83 pmol/mg protein, respectively) but significantly increased for MCD (1.67 to 4.17 pmol/mg protein), suggesting that the mouse models are comparable to human for these specific transport processes. These data suggest that variations in rodent renal transporter expression are elicited by NASH, and the concordance analysis enables appropriate model selection for future pharmacokinetic studies based on transporter specificity. These models provide a valuable resource to extrapolate the consequences of human variability in renal drug elimination. SIGNIFICANCE STATEMENT: Rodent models of nonalcoholic steatohepatitis that recapitulate human renal transporter alterations are identified for future transporter-specific pharmacokinetic studies to facilitate the prevention of adverse drug reactions due to human variability.
doi_str_mv 10.1124/dmd.122.001133
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10353148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2809547557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-c574537093b746c8f590d1085eb89b28e1f3f575dbd80582676717c27a4bf8033</originalsourceid><addsrcrecordid>eNpVkc1LwzAchoMobk6vHiVHL535aJr0JEPUCVNhTvAW0jZ1kbapSTrwvzeyOfSSN5Dn9ybhAeAcoynGJL2q2mqKCZkihDGlB2CMGcEJQvnbIRjHQEnOWDYCJ95_RCZNaX4MRpRjyjnOx6Ba6t5pr7uggtlouLRV3MPHGI2HtXVwqTvVwJVTne-tC9rBWRPXiNvOQ9PB-dCqDj7ZiJV2bRtTwpegVbBr3UcqGH8KjmrVeH22ywl4vbtd3cyTxfP9w81skZSEZyEpGU8Z5SinBU-zUtQsRxVGgulC5AURGte0ZpxVRSUQEyTjGcc8zqq0qAWidAKut739ULS6KuNPnGpk70yr3Je0ysj_J51Zy3e7kRhRRnEqYsPlrsHZz0H7IFvjS900qtN28JIIlLOUM8YjOt2ipbPeO13v78FI_riR0Y2MbuTWTRy4-Pu6Pf4rg34DFzKMVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2809547557</pqid></control><display><type>article</type><title>Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Frost, Kayla L ; Jilek, Joseph L ; Toth, Erica L ; Goedken, Michael J ; Wright, Stephen H ; Cherrington, Nathan J</creator><creatorcontrib>Frost, Kayla L ; Jilek, Joseph L ; Toth, Erica L ; Goedken, Michael J ; Wright, Stephen H ; Cherrington, Nathan J</creatorcontrib><description>Alterations in renal elimination processes of glomerular filtration and active tubular secretion by renal transporters can result in adverse drug reactions. Nonalcoholic steatohepatitis (NASH) alters hepatic transporter expression and xenobiotic elimination, but until recently, renal transporter alterations in NASH were unknown. This study investigates renal transporter changes in rodent models of NASH to identify a model that recapitulates human alterations. Quantitative protein expression by surrogate peptide liquid chromatography-coupled mass spectrometry (LC-MS/MS) on renal biopsies from NASH patients was used for concordance analysis with rodent models, including methionine/choline deficient (MCD), atherogenic (Athero), or control rats and MCD ( ), C57BL/6J fast-food thioacetamide (FFDTH), American lifestyle-induced obesity syndrome (ALIOS), or control mice. Demonstrating clinical similarity to NASH patients, FFDTH, and ALIOS showed decreases in glomerular filtration rate (GFR) by 76%, 28%, and 24%. Organic anion transporter 3 (OAT3) showed an upward trend in all models except the FFDTH (from 3.20 to 2.39 pmol/mg protein), making the latter the only model to represent human OAT3 changes. OAT5, a functional ortholog of human OAT4, significantly decreased in FFDTH, and ALIOS (from 4.59 to 0.45, 1.59, and 2.83 pmol/mg protein, respectively) but significantly increased for MCD (1.67 to 4.17 pmol/mg protein), suggesting that the mouse models are comparable to human for these specific transport processes. These data suggest that variations in rodent renal transporter expression are elicited by NASH, and the concordance analysis enables appropriate model selection for future pharmacokinetic studies based on transporter specificity. These models provide a valuable resource to extrapolate the consequences of human variability in renal drug elimination. SIGNIFICANCE STATEMENT: Rodent models of nonalcoholic steatohepatitis that recapitulate human renal transporter alterations are identified for future transporter-specific pharmacokinetic studies to facilitate the prevention of adverse drug reactions due to human variability.</description><identifier>ISSN: 0090-9556</identifier><identifier>ISSN: 1521-009X</identifier><identifier>EISSN: 1521-009X</identifier><identifier>DOI: 10.1124/dmd.122.001133</identifier><identifier>PMID: 37137719</identifier><language>eng</language><publisher>United States: The American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Animals ; Choline - metabolism ; Chromatography, Liquid ; Disease Models, Animal ; Humans ; Liver - metabolism ; Membrane Transport Proteins - metabolism ; Methionine - metabolism ; Mice ; Mice, Inbred C57BL ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity - metabolism ; Rats ; Rodentia - metabolism ; Tandem Mass Spectrometry</subject><ispartof>Drug metabolism and disposition, 2023-08, Vol.51 (8), p.970-981</ispartof><rights>Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics.</rights><rights>Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c276t-c574537093b746c8f590d1085eb89b28e1f3f575dbd80582676717c27a4bf8033</cites><orcidid>0000-0003-4215-9434</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37137719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frost, Kayla L</creatorcontrib><creatorcontrib>Jilek, Joseph L</creatorcontrib><creatorcontrib>Toth, Erica L</creatorcontrib><creatorcontrib>Goedken, Michael J</creatorcontrib><creatorcontrib>Wright, Stephen H</creatorcontrib><creatorcontrib>Cherrington, Nathan J</creatorcontrib><title>Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis</title><title>Drug metabolism and disposition</title><addtitle>Drug Metab Dispos</addtitle><description>Alterations in renal elimination processes of glomerular filtration and active tubular secretion by renal transporters can result in adverse drug reactions. Nonalcoholic steatohepatitis (NASH) alters hepatic transporter expression and xenobiotic elimination, but until recently, renal transporter alterations in NASH were unknown. This study investigates renal transporter changes in rodent models of NASH to identify a model that recapitulates human alterations. Quantitative protein expression by surrogate peptide liquid chromatography-coupled mass spectrometry (LC-MS/MS) on renal biopsies from NASH patients was used for concordance analysis with rodent models, including methionine/choline deficient (MCD), atherogenic (Athero), or control rats and MCD ( ), C57BL/6J fast-food thioacetamide (FFDTH), American lifestyle-induced obesity syndrome (ALIOS), or control mice. Demonstrating clinical similarity to NASH patients, FFDTH, and ALIOS showed decreases in glomerular filtration rate (GFR) by 76%, 28%, and 24%. Organic anion transporter 3 (OAT3) showed an upward trend in all models except the FFDTH (from 3.20 to 2.39 pmol/mg protein), making the latter the only model to represent human OAT3 changes. OAT5, a functional ortholog of human OAT4, significantly decreased in FFDTH, and ALIOS (from 4.59 to 0.45, 1.59, and 2.83 pmol/mg protein, respectively) but significantly increased for MCD (1.67 to 4.17 pmol/mg protein), suggesting that the mouse models are comparable to human for these specific transport processes. These data suggest that variations in rodent renal transporter expression are elicited by NASH, and the concordance analysis enables appropriate model selection for future pharmacokinetic studies based on transporter specificity. These models provide a valuable resource to extrapolate the consequences of human variability in renal drug elimination. SIGNIFICANCE STATEMENT: Rodent models of nonalcoholic steatohepatitis that recapitulate human renal transporter alterations are identified for future transporter-specific pharmacokinetic studies to facilitate the prevention of adverse drug reactions due to human variability.</description><subject>Animals</subject><subject>Choline - metabolism</subject><subject>Chromatography, Liquid</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Liver - metabolism</subject><subject>Membrane Transport Proteins - metabolism</subject><subject>Methionine - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity - metabolism</subject><subject>Rats</subject><subject>Rodentia - metabolism</subject><subject>Tandem Mass Spectrometry</subject><issn>0090-9556</issn><issn>1521-009X</issn><issn>1521-009X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1LwzAchoMobk6vHiVHL535aJr0JEPUCVNhTvAW0jZ1kbapSTrwvzeyOfSSN5Dn9ybhAeAcoynGJL2q2mqKCZkihDGlB2CMGcEJQvnbIRjHQEnOWDYCJ95_RCZNaX4MRpRjyjnOx6Ba6t5pr7uggtlouLRV3MPHGI2HtXVwqTvVwJVTne-tC9rBWRPXiNvOQ9PB-dCqDj7ZiJV2bRtTwpegVbBr3UcqGH8KjmrVeH22ywl4vbtd3cyTxfP9w81skZSEZyEpGU8Z5SinBU-zUtQsRxVGgulC5AURGte0ZpxVRSUQEyTjGcc8zqq0qAWidAKut739ULS6KuNPnGpk70yr3Je0ysj_J51Zy3e7kRhRRnEqYsPlrsHZz0H7IFvjS900qtN28JIIlLOUM8YjOt2ipbPeO13v78FI_riR0Y2MbuTWTRy4-Pu6Pf4rg34DFzKMVw</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Frost, Kayla L</creator><creator>Jilek, Joseph L</creator><creator>Toth, Erica L</creator><creator>Goedken, Michael J</creator><creator>Wright, Stephen H</creator><creator>Cherrington, Nathan J</creator><general>The American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4215-9434</orcidid></search><sort><creationdate>202308</creationdate><title>Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis</title><author>Frost, Kayla L ; Jilek, Joseph L ; Toth, Erica L ; Goedken, Michael J ; Wright, Stephen H ; Cherrington, Nathan J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-c574537093b746c8f590d1085eb89b28e1f3f575dbd80582676717c27a4bf8033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Choline - metabolism</topic><topic>Chromatography, Liquid</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Liver - metabolism</topic><topic>Membrane Transport Proteins - metabolism</topic><topic>Methionine - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity - metabolism</topic><topic>Rats</topic><topic>Rodentia - metabolism</topic><topic>Tandem Mass Spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frost, Kayla L</creatorcontrib><creatorcontrib>Jilek, Joseph L</creatorcontrib><creatorcontrib>Toth, Erica L</creatorcontrib><creatorcontrib>Goedken, Michael J</creatorcontrib><creatorcontrib>Wright, Stephen H</creatorcontrib><creatorcontrib>Cherrington, Nathan J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drug metabolism and disposition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frost, Kayla L</au><au>Jilek, Joseph L</au><au>Toth, Erica L</au><au>Goedken, Michael J</au><au>Wright, Stephen H</au><au>Cherrington, Nathan J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis</atitle><jtitle>Drug metabolism and disposition</jtitle><addtitle>Drug Metab Dispos</addtitle><date>2023-08</date><risdate>2023</risdate><volume>51</volume><issue>8</issue><spage>970</spage><epage>981</epage><pages>970-981</pages><issn>0090-9556</issn><issn>1521-009X</issn><eissn>1521-009X</eissn><abstract>Alterations in renal elimination processes of glomerular filtration and active tubular secretion by renal transporters can result in adverse drug reactions. Nonalcoholic steatohepatitis (NASH) alters hepatic transporter expression and xenobiotic elimination, but until recently, renal transporter alterations in NASH were unknown. This study investigates renal transporter changes in rodent models of NASH to identify a model that recapitulates human alterations. Quantitative protein expression by surrogate peptide liquid chromatography-coupled mass spectrometry (LC-MS/MS) on renal biopsies from NASH patients was used for concordance analysis with rodent models, including methionine/choline deficient (MCD), atherogenic (Athero), or control rats and MCD ( ), C57BL/6J fast-food thioacetamide (FFDTH), American lifestyle-induced obesity syndrome (ALIOS), or control mice. Demonstrating clinical similarity to NASH patients, FFDTH, and ALIOS showed decreases in glomerular filtration rate (GFR) by 76%, 28%, and 24%. Organic anion transporter 3 (OAT3) showed an upward trend in all models except the FFDTH (from 3.20 to 2.39 pmol/mg protein), making the latter the only model to represent human OAT3 changes. OAT5, a functional ortholog of human OAT4, significantly decreased in FFDTH, and ALIOS (from 4.59 to 0.45, 1.59, and 2.83 pmol/mg protein, respectively) but significantly increased for MCD (1.67 to 4.17 pmol/mg protein), suggesting that the mouse models are comparable to human for these specific transport processes. These data suggest that variations in rodent renal transporter expression are elicited by NASH, and the concordance analysis enables appropriate model selection for future pharmacokinetic studies based on transporter specificity. These models provide a valuable resource to extrapolate the consequences of human variability in renal drug elimination. SIGNIFICANCE STATEMENT: Rodent models of nonalcoholic steatohepatitis that recapitulate human renal transporter alterations are identified for future transporter-specific pharmacokinetic studies to facilitate the prevention of adverse drug reactions due to human variability.</abstract><cop>United States</cop><pub>The American Society for Pharmacology and Experimental Therapeutics</pub><pmid>37137719</pmid><doi>10.1124/dmd.122.001133</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-4215-9434</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0090-9556
ispartof Drug metabolism and disposition, 2023-08, Vol.51 (8), p.970-981
issn 0090-9556
1521-009X
1521-009X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10353148
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Choline - metabolism
Chromatography, Liquid
Disease Models, Animal
Humans
Liver - metabolism
Membrane Transport Proteins - metabolism
Methionine - metabolism
Mice
Mice, Inbred C57BL
Non-alcoholic Fatty Liver Disease - metabolism
Obesity - metabolism
Rats
Rodentia - metabolism
Tandem Mass Spectrometry
title Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A14%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Representative%20Rodent%20Models%20for%20Renal%20Transporter%20Alterations%20in%20Human%20Nonalcoholic%20Steatohepatitis&rft.jtitle=Drug%20metabolism%20and%20disposition&rft.au=Frost,%20Kayla%20L&rft.date=2023-08&rft.volume=51&rft.issue=8&rft.spage=970&rft.epage=981&rft.pages=970-981&rft.issn=0090-9556&rft.eissn=1521-009X&rft_id=info:doi/10.1124/dmd.122.001133&rft_dat=%3Cproquest_pubme%3E2809547557%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2809547557&rft_id=info:pmid/37137719&rfr_iscdi=true